These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19931906)

  • 1. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
    Ustaalioglu BB; Bilici A; Seker M; Canpolat N; Ozdemir N; Salepci T; Gumus M
    Leuk Res; 2010 Apr; 34(4):e108-10. PubMed ID: 19931906
    [No Abstract]   [Full Text] [Related]  

  • 2. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
    Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
    Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
    Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
    Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of primary cardiac lymphoma: analysis of the role of echocardiography in early diagnosis.
    Faganello G; Belham M; Thaman R; Blundell J; Eller T; Wilde P
    Echocardiography; 2007 Sep; 24(8):889-92. PubMed ID: 17767544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
    Chakravarti A; Leslie WT; Venugopal P
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
    [No Abstract]   [Full Text] [Related]  

  • 6. High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).
    Vassallo E; Di Noto L; Palmeri L; Vaglica M; Pancera G; Palmeri S
    Leuk Lymphoma; 2006 Aug; 47(8):1686-7. PubMed ID: 16966287
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
    Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
    Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary endometrial non-Hodgkin's lymphoma treated by chemotherapy and radiotherapy.
    Guldrís EM; Vázquez P; Fernández A
    Acta Obstet Gynecol Scand; 2013 May; 92(5):606. PubMed ID: 23398244
    [No Abstract]   [Full Text] [Related]  

  • 9. A meta-analysis on Rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China.
    Hou S; Yang W
    Saudi Med J; 2011 Jul; 32(7):675-8. PubMed ID: 21748202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
    Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
    Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
    Hainsworth JD; Spigel DR; Markus TM; Shipley D; Thompson D; Rotman R; Dannaher C; Greco FA
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):223-8. PubMed ID: 19525191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
    [No Abstract]   [Full Text] [Related]  

  • 13. The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
    Adams HJA; Kwee TC
    Ann Hematol; 2018 Apr; 97(4):719-720. PubMed ID: 29222579
    [No Abstract]   [Full Text] [Related]  

  • 14. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
    Korolenko VO; Gershanovich ML; Tikhonova VV
    Vopr Onkol; 2004; 50(4):421-5. PubMed ID: 15605764
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary non-Hodgkin,s lymphoma of the uterine cervix.
    Hanprasertpong J; Hanprasertpong T; Thammavichit T; Kongkabpan D; Tungsinmunkong K; Chandeying N
    Asian Pac J Cancer Prev; 2008; 9(2):363-6. PubMed ID: 18712992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of lymphoma with respect to pathologic classification: updates and controversies].
    Zhu J; Song YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009
    [No Abstract]   [Full Text] [Related]  

  • 17. [No Hodgkin lymphoma that mistakes with a colonic neoplasm].
    Rodríguez Framil M; Martínez Rey C; González S; Alende Sixto R
    An Med Interna; 2007 Apr; 24(4):203-4. PubMed ID: 17879482
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
    Paschal BR
    Leuk Lymphoma; 2003 Apr; 44(4):731-3. PubMed ID: 12769354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
    Bibb J; Hromas R; Rabinowitz I
    J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete regression of cardiac non-Hodgkin lymphoma.
    Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
    Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.